- Home
- CYRX vs KMDA Comparison
CYRX vs KMDA Comparison
Compare CYRX & KMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CYRX | KMDA |
|---|---|---|
| Founded | 1999 | 1990 |
| Country | United States | Israel |
| Employees | 1100 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.6M | 458.6M |
| IPO Year | 2008 | 2013 |
Fundamental Metrics
Financial Performance| Metric | CYRX | KMDA |
|---|---|---|
| Price | $8.05 | $8.92 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $12.94 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 341.9K | 65.5K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.21% |
| EPS Growth | ★ 156.22 | N/A |
| EPS | ★ 1.40 | N/A |
| Revenue | ★ $176,177,000.00 | N/A |
| Revenue This Year | $9.71 | $14.79 |
| Revenue Next Year | $9.56 | $11.38 |
| P/E Ratio | ★ $4.99 | $24.59 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $4.63 | $5.54 |
| 52 Week High | $11.45 | $9.35 |
Technical Indicators
Market Signals| Indicator | CYRX | KMDA |
|---|---|---|
| Relative Strength Index (RSI) | 37.26 | 56.02 |
| Support Level | $6.57 | $6.69 |
| Resistance Level | $8.45 | $9.35 |
| Average True Range (ATR) | 0.51 | 0.27 |
| MACD | 0.04 | -0.02 |
| Stochastic Oscillator | 25.71 | 60.00 |
Price Performance
Historical ComparisonAbout CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
About KMDA Kamada Ltd.
Kamada Ltd is a drug-focused, plasma-derived protein therapeutics company. It is involved in the business of developing, producing, and marketing specialty therapeutics using protein purification proprietary technology. Its product portfolio consists of Glassia, Bramitob, Foster, Ixiaro, Factor-IX, and others. The company has two segments namely, the Proprietary Products segment and the Distribution segment. It derives the majority of its revenue from the Proprietary products segment. The firm categorizes its products in Lung Disease, Vaccines, Haemophilia, Immunoglobulins, Critical care, and Diagnostics.